Inscobee Inc. - Insider Trading & Ownership

Location
Room 613, Digital Ro 130, 6 F, Geumcheon Gu, Seoul, Korea, Republic of
Summary
The estimated value of insider holdings of Inscobee Inc. is at least $5.46M dollars as of June 11, 2025. Inscobee Inc. is the 10%+ Owner of Apimeds Pharmaceuticals US, Inc. and owns shares of Apimeds Pharmaceuticals US, Inc. (APUS) stock worth about $5.46M.
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Inscobee Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APUS Apimeds Pharmaceuticals US, Inc. 10%+ Owner $5.46M May 12, 2025

Insider Transactions Reported by Inscobee Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.